2007 Annual Meeting | Stroke Therapy

Date Thursday 05/03/07

Time 07:00 PM - 09:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Therapy Program

Director(s) Marc Fisher, MD, FAAN

Topic(s)

Learning Objectives Participants should be aware of the results of recently completed antithrombotic and statin trials related to stroke prevention and how these results will likely impact upon clinical practice; be aware of the SAINT trials of the neuroprotective agent NXY-059 and whether or not it is likely to be approved; gain information about the status of other acute stroke therapies in development as well as how the time window for acute therapy can be expanded; and become familiar with the current status of interventional approaches to stroke prevention and acute therapy.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:45 PM - 09:00 PM		Reception
07:00 PM - 07:30 PM		Stroke Prevention Update Marc Fisher, MD, FAAN
07:30 PM - 08:00 PM		Pharmacological Approaches to Acute Stroke Treatment Walter J. Koroshetz, MD, FAAN
08:00 PM - 08:30 PM		Interventional Approaches to Acute Stroke Therapy Italo Linfante, MD
08:30 PM - 09:00 PM		Discussion and Questions

Faculty Disclosures
Marc Fisher, MD, FAAN	Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SimcereUSA. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SimcereUSA. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo. Dr. Fisher has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Walter J. Koroshetz, MD, FAAN	Dr. Koroshetz has nothing to disclose.
Italo Linfante, MD	Dr. Linfante has received personal compensation for serving as an employee of medtronic. Dr. Linfante has received personal compensation for serving as an employee of stryker. Dr. Linfante has received personal compensation for serving as an employee of cerenovus. Dr. Linfante has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for medtronic. Dr. Linfante has received stock or an ownership interest from InNeuroCO. Dr. Linfante has received stock or an ownership interest from Stryker/Surpass.

��ɫ��

��ɫ��